Pandey Manjari, Martin Mike G
University of Tennessee Health Science Center and West Cancer Center, Memphis, Tennessee, USA.
World J Oncol. 2014 Jun;5(3):144-148. doi: 10.14740/wjon809w. Epub 2014 Jun 25.
Angiosarcoma of the breast (ASB) is a rare but aggressive tumor with very poor prognosis. It is important to recognize this tumor early and to distinguish between primary and secondary ASB. While mammograms frequently miss these lesions, ultrasound and MRI show promise as imaging modalities. In spite of characteristic features described on pathology, misdiagnosis is common, with over 35% tumors initially thought to be benign. We present the case of a 32-year-old woman with a history of bilateral reduction mammoplasty who presented with a non-tender lump in her right breast. After repeated aspirations and biopsies, a diagnosis of primary ASB was made. She underwent bilateral simple mastectomies followed by adjuvant chemo-therapy and radiation. While surgery is the mainstay of treatment, roles of radiation and chemo-therapy are still evolving; we review the literature and discuss the decision pathways for diagnosis and management of this rare tumor.
乳腺血管肉瘤(ASB)是一种罕见但侵袭性强、预后极差的肿瘤。早期识别这种肿瘤并区分原发性和继发性ASB很重要。虽然乳房X线摄影经常漏诊这些病变,但超声和磁共振成像(MRI)作为成像方式显示出前景。尽管病理学上描述了其特征性表现,但误诊很常见,超过35%的肿瘤最初被认为是良性的。我们报告一例32岁有双侧乳房缩小成形术病史的女性,她右乳出现一个无压痛肿块。经过多次抽吸和活检后,确诊为原发性ASB。她接受了双侧单纯乳房切除术,随后进行辅助化疗和放疗。虽然手术是主要治疗手段,但放疗和化疗的作用仍在不断演变;我们回顾文献并讨论这种罕见肿瘤的诊断和管理决策途径。